Welcome to Therakos Research

Working with the Global Research Community to Advance ECP Immunomodulation


Over the past 30 years, the progress we have made — both technically and clinically — in pursuing ECP Immunomodulation has been fuelled by extensive engagement with the global scientific and medical communities. We believe the future of ECP Immunomodulation also depends on such a collaboration and on the research questions we answer together.
We are committed to supporting research that contributes to our understanding of the ECP Immunomodulation, helps us refine its delivery, and explores its applications in the treatment of immune-mediated diseases and the improvement of human health.

Mallinckrodt, the 'M' brand mark, the Mallinckrodt Pharmaceuticals logo and other brands are trademarks of a Mallinckrodt company.


© 2018 Mallinckrodt. Mallinckrodt Pharmaceuticals is a registered business name of Mallinckrodt plc, which is registered in Ireland as a public limited company with registration number 522227 and has its registered office at Damastown, Mulhuddart, Dublin 15, Ireland.